Enlivex Therapeutics Ltd.

NASDAQ: ENLV · Real-Time Price · USD
1.82
0.04 (2.25%)
At close: Aug 15, 2025, 3:59 PM
1.91
4.95%
After-hours: Aug 15, 2025, 07:55 PM EDT

Enlivex Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-15.01M -29.07M -31.06M -14.47M
Depreciation & Amortization
545K 835K 777K 546K
Stock-Based Compensation
n/a 1.95M 2.71M 2.91M
Other Working Capital
-1.64M -1.3M -364K -1.8M
Other Non-Cash Items
2.68M 4.58M 2.81M 413K
Deferred Income Tax
n/a n/a n/a -5.59M
Change in Working Capital
-1.22M -1.82M 804K -1.36M
Operating Cash Flow
-13.01M -23.52M -23.95M -17.54M
Capital Expenditures
-103K -236K -8.12M -1.63M
Cash Acquisitions
n/a n/a -9.71M -20.03M
Purchase of Investments
-32.37M -26.17M -1.61M -104.42M
Sales Maturities Of Investments
39.24M 301K 72.25M 67.63M
Other Investing Acitivies
2.29M 133K 9.71M 20.03M
Investing Cash Flow
9.06M -25.97M 62.52M -38.41M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
2K n/a 150K 7.81M
Financial Cash Flow
6.45M 360K 150K 60.98M
Net Cash Flow
2.5M -49.13M 38.72M 4.62M
Free Cash Flow
-13.11M -23.76M -32.08M -19.17M